Garofalo Health Care Valuation Multiples

Garofalo Health Care is valued at $539M as of October 2026, a 1.4x revenue multiple. In the last 12 months, Garofalo Health Care revenue was $570M and Garofalo Health Care EBITDA was $92M.

Garofalo Health Care Overview

About Garofalo Health Care

Garofalo Health Care SpA operates accredited private healthcare facilities and is based in Rome. The company offers outpatient services and other range of other services, including surgery, emergency medicine, clinical, interventional cardiology, nutritional rehabilitation, and diagnostic centers, among others. The Group mainly operates in regions of northern and central Italy that have been selected as attractive in terms of: i) per capita health spending, ii) above-average per capita income for Italy; iii) sound financial health of the Regional Health Service; and iv) internal transport infrastructure.


Founded

2000

HQ

Italy

Employees

2.7K

Financials (LTM)

Revenue: $570M
EBITDA: $92M

EV

$796M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Garofalo Health Care Financials

Garofalo Health Care reported last 12-month revenue of $570M and EBITDA of $92M.

In the same LTM period, Garofalo Health Care generated $92M in EBITDA and $24M in net income.

Revenue (LTM)


Garofalo Health Care P&L

In the most recent fiscal year, Garofalo Health Care reported revenue of $543M and EBITDA of $81M.

Garofalo Health Care is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 15%, and net margin of 5%.

See analyst estimates for Garofalo Health Care
LTMLast FY202320242025202620272028
Revenue$570M$543M$424M$541M$543M
Gross Profit-$459M$366M$460M$459M
Gross Margin-85%86%85%85%
EBITDA$92M$81M$70M$81M$81M
EBITDA Margin16%15%17%15%15%
EBIT Margin8%11%13%12%11%
Net Profit$24M$26M$24M$25M$26M
Net Margin4%5%6%5%5%
Net Debt-$209M---

Financial data powered by Morningstar, Inc.

Garofalo Health Care Stock Performance

Garofalo Health Care has current market cap of $539M, and enterprise value of $796M.

Market Cap Evolution


Garofalo Health Care's stock price is $6.09.

Garofalo Health Care share price decreased by 1.2% in the last 30 days, and increased by 0.6% in the last year.

Garofalo Health Care has an EPS (earnings per share) of $0.30.

See more trading valuation data for Garofalo Health Care
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$796M$539M0.3%-1.2%-6.4%0.6%$0.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Garofalo Health Care Valuation Multiples

Garofalo Health Care trades at 1.4x EV/Revenue multiple, and 8.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Garofalo Health Care

EV / Revenue (LTM)


Garofalo Health Care Financial Valuation Multiples

As of October 16, 2026, Garofalo Health Care has market cap of $539M and EV of $796M.

Garofalo Health Care has a P/E ratio of 22.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.5x1.9x1.5x1.5x
EV/EBITDA8.7x9.8x11.3x9.8x9.8x
EV/EBIT16.5x12.9x14.8x12.5x12.9x
EV/Gross Profit-1.7x2.2x1.7x1.7x
P/E22.3x20.6x22.4x21.5x20.6x
EV/FCF20.5x45.8x20.9x51.3x45.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Garofalo Health Care Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Garofalo Health Care Margins & Growth Rates

Garofalo Health Care grew revenue by 5% and EBITDA by 12% in the last fiscal year.

In the most recent fiscal year, Garofalo Health Care reported gross margin of 85%, EBITDA margin of 15%, and net margin of 5%.

See estimated margins and future growth rates for Garofalo Health Care

Garofalo Health Care Margins

Last FY202420252026202720282029
Gross Margin85%85%85%-
EBITDA Margin15%15%15%16%
EBIT Margin11%12%11%8%
Net Margin5%5%5%4%
FCF Margin3%3%3%7%

Garofalo Health Care Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%28%0%5%
Gross Profit Growth-26%(0%)-
EBITDA Growth12%15%0%12%
EBIT Growth(24%)18%(3%)(24%)
Net Profit Growth(11%)4%4%(11%)
FCF Growth126%(59%)12%126%

Data powered by FactSet, Inc. and Morningstar, Inc.

Garofalo Health Care Operational KPIs

Garofalo Health Care's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Garofalo Health Care's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Garofalo Health Care's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Garofalo Health Care
LTMLast FY202320242025202620272028
Rule of 4023%21%---
Bessemer Rule of X33%28%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.2M---
G&A Expenses to Revenue-1%1%1%1%
Opex to Revenue-84%74%73%84%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Garofalo Health Care Competitors

Garofalo Health Care competitors include Integral Diagnostics, Chularat Hospital, Global Medical Response, Al-Maidan Dental Clinic, Hermina Hospitals, Sikarin, Saudi German Health, Community Health Systems, M1 Kliniken and Mater Dei.

Most Garofalo Health Care public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Integral Diagnostics$549M$96M1.7x1.6x9.7x7.8x
Chularat Hospital$249M$52M2.0x1.9x9.8x9.4x
Global Medical Response$5.7B$1.1B0.9x0.8x4.6x-
Al-Maidan Dental Clinic$204M$37M2.0x-10.9x-
Hermina Hospitals$398M$103M1.9x1.8x7.4x6.8x
Sikarin$180M$47M2.5x-9.8x-
Saudi German Health$827M$204M1.6x1.6x6.4x7.7x
Community Health Systems$12B$2B0.9x0.9x5.5x8.2x

This data is available for Pro users. Sign up to see all Garofalo Health Care competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Garofalo Health Care

When was Garofalo Health Care founded?Garofalo Health Care was founded in 2000.
Where is Garofalo Health Care headquartered?Garofalo Health Care is headquartered in Italy.
How many employees does Garofalo Health Care have?As of today, Garofalo Health Care has over 2K employees.
Is Garofalo Health Care publicly listed?Yes, Garofalo Health Care is a public company listed on Borsa Italiana.
What is the stock symbol of Garofalo Health Care?Garofalo Health Care trades under GHC ticker.
When did Garofalo Health Care go public?Garofalo Health Care went public in 2018.
Who are competitors of Garofalo Health Care?Garofalo Health Care main competitors include Integral Diagnostics, Chularat Hospital, Global Medical Response, Al-Maidan Dental Clinic, Hermina Hospitals, Sikarin, Saudi German Health, Community Health Systems, M1 Kliniken, Mater Dei.
What is the current market cap of Garofalo Health Care?Garofalo Health Care's current market cap is $539M.
What is the current revenue of Garofalo Health Care?Garofalo Health Care's last 12 months revenue is $570M.
What is the current revenue growth of Garofalo Health Care?Garofalo Health Care revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Garofalo Health Care?Current revenue multiple of Garofalo Health Care is 1.4x.
What is the current EBITDA of Garofalo Health Care?Garofalo Health Care's last 12 months EBITDA is $92M.
What is Garofalo Health Care's EBITDA margin?Garofalo Health Care's last 12 months EBITDA margin is 16%.
What is the current EV/EBITDA multiple of Garofalo Health Care?Current EBITDA multiple of Garofalo Health Care is 8.7x.
What is the current FCF of Garofalo Health Care?Garofalo Health Care's last 12 months FCF is $39M.
What is Garofalo Health Care's FCF margin?Garofalo Health Care's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Garofalo Health Care?Current FCF multiple of Garofalo Health Care is 20.5x.
How many companies Garofalo Health Care has acquired to date?Garofalo Health Care hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Garofalo Health Care has invested to date?Garofalo Health Care hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Garofalo Health Care

Lists including Garofalo Health Care

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial